Psychiatric Disorders: Clinical Trials

2 trials for Psychiatric Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 32Completed 1, Recruiting 1

Follow Psychiatric Disorders: new trials by email Literature Review of Psychiatric Disorders trials Research Report on Psychiatric Disorders

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
Melatonin, Quetiapine, Placebo - Psychiatric Disorders, Insomnia
Phase 2 / Phase 3RecruitingLone Baandrup2552023-09-182025-04-24
Can Brief-mindfulness Interventions Improve Psychiatric Symptoms?
Mindfulness-oriented intervention - Psychiatric Disorders
Phase 2 / Phase 3CompletedLady Davis Institute202017-05-192020-09-16

Narrower conditions

Mental Disorders (2)  ·  Sleep Initiation and Maintenance Disorders (1)

Broader conditions

Dyssomnias (1)  ·  Nervous System Diseases (1)  ·  Sleep Disorders, Intrinsic (1)  ·  Sleep Wake Disorders (1)

Interventions

Melatonin (1)  ·  Quetiapine Fumarate (1)

Sponsors

Lady Davis Institute (1)  ·  Lone Baandrup (1)

Countries

Canada (1)  ·  Denmark (1)

Top investigators

Lone Baandrup, MD (1)

NIH funding

2023 (1)